Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2018

01-02-2018 | Gynecologic Oncology

Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study

Authors: A. Martinez, PhD, MD, T. Filleron, PhD, MD, P. Rouanet, PhD, MD, P. Méeus, PhD, MD, E. Lambaudie, PhD, MD, J. M. Classe, PhD, MD, F. Foucher, MD, F. Narducci, MD, S. Gouy, PhD, MD, F. Guyon, PhD, MD, F. Marchal, PhD, MD, E. Jouve, MD, P. E. Colombo, PhD, MD, A. Mourregot, MD, M. Rivoire, PhD, MD, N. Chopin, MD, G. Houvenaeghel, PhD, MD, I. Jaffre, MD, J. Leveque, PhD, MD, V. Lavoue, PhD, MD, E. Leblanc, PhD, MD, P. Morice, PhD, MD, E. Stoeckle, PhD, MD, J. L. Verheaghe, MD, D. Querleu, PhD, MD, G. Ferron, PhD, MD

Published in: Annals of Surgical Oncology | Issue 2/2018

Login to get access

Abstract

Background

Pelvic exenteration remains one of the most mutilating procedures, with important postoperative morbidity, an altered body image, and long-term physical and psychosocial concerns. This study aimed to assess quality of life (QOL) during the first year after pelvic exenteration for gynecologic malignancy performed with curative intent.

Methods

A French multicentric prospective study was performed by including patients who underwent pelvic exenteration. Quality of life by measurement of functional and symptom scales was assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 (version 3.0) and the EORTC QLQ-OV28 questionnaires before surgery, at baseline, and 1, 3, 6, and 12 months after the procedure.

Results

The study enrolled 97 patients. Quality of life including physical, personal, fatigue, and anorexia reported in the QLQ-C30 was significantly reduced 1 month postoperatively and improved at least to baseline level 1 year after the procedure. Body image also was significantly reduced 1 month postoperatively. Global health, emotional, dyspnea, and anorexia items were significantly improved 1 year after surgery compared with baseline values. Unlike younger patients, elderly patients did not regain physical and social activities after pelvic exenteration.

Conclusions

Therapeutic decision on performing a pelvic exenteration can have a severe and permanent impact on all aspects of patients’ QOL. Deterioration of QOL was most significant during the first 3 months after surgery. Elderly patients were the only group of patients with permanent decreased physical and social function. Preoperative evaluation and postoperative follow-up evaluation should include health-related QOL instruments, counseling by a multidisciplinary team to cover all aspects concerning stoma care, sexual function, and long-term concerns after surgery.
Literature
1.
Marnitz S, Köhler C, Müller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol. 2006;103:1023–30.CrossRefPubMed
2.
Maggioni A, Roviglione G, Landoni F, et al. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol. 2009;114:64–6.CrossRefPubMed
3.
Ungar L, Palafavi L, Novak Z. Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol. 2008;111:S9–12.CrossRefPubMed
4.
Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, et al. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014;134:546–51.CrossRefPubMedPubMedCentral
5.
Chiva LM, Lapuente F, González-Cortijo L, González-Martín A, Rojo A, García JF, Carballo N. Surgical treatment of recurrent cervical cancer: state of the art and new achievements. Gynecol Oncol. 2008;110(3 Suppl 2):S60–6.CrossRefPubMed
6.
Ferron G, Gangloff D, Querleu D, Frigenza M, Torrent JJ, Picaud L, et al. Vaginal reconstruction with pedicled vertical deep inferior epigastric perforator flap (DIEP) after pelvic exenteration: a consecutive case series. Gynecol Oncol. 2015;138:603–8.CrossRefPubMed
7.
Jurado M, Bazán A, Alcázar JL, Garcia-Tutor E. Primary vaginal reconstruction at the time of pelvic exenteration for gynecologic cancer: morbidity revisited. Ann Surg Oncol. 2009;16:121–7.CrossRefPubMed
8.
Harji DP, Griffiths B, Velikova G, Sagar PM, Brown J. Systematic review of health-related quality of life in patients undergoing pelvic exenteration. Eur J Surg Oncol. 2016;42:1132–45.CrossRefPubMed
9.
Rezk YA, Hurley KE, Carter J, Dao F, Bochner BH, Aubey JJ, et al. A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol. 2013;128:191–7.CrossRefPubMed
10.
Martinez A, Filleron T, Vitse L, et al. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage? Gynecol Oncol. 2011;120:374–9.CrossRefPubMed
11.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed
12.
Cull A, Howat S, Greimel E, et al. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. Eur J Cancer. 2001;37:47–53.CrossRefPubMed
13.
Greimel E, Bottomley A, Cull A, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39:1402–8.CrossRefPubMed
14.
15.
Höckel M. Laterally extended endopelvic resection (LEER): principles and practice. Gynecol Oncol. 2008;111:S13–7CrossRefPubMed
16.
Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, et al. The impact of treatment for genital cancer on quality of life and body image: results of a prospective longitudinal 10-year study. Gynecol Oncol. 2004;94:398–403.CrossRefPubMed
17.
Roos EJ, de Graeff A, van Eijkeren MA, et al. Quality of life after pelvic exenteration. Gynecol Oncol. 2004;93:610–14.CrossRefPubMed
18.
19.
Breetvelt IS, Van Dam FS. Underreporting by cancer patients: the case of response-shift. Soc Sci Med. 1991;32:981–7.CrossRefPubMed
20.
Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol. 2002;20:4361–7.CrossRefPubMed
21.
Young JM, Badgery-Parker T, Masya LM, King M, Koh C, Lynch AC, et al. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. Br J Surg. 2014;101:277–87.CrossRefPubMed
22.
Austin KK, Young JM, Solomon MJ. Quality of life of survivors after pelvic exenteration for rectal cancer. Dis Colon Rectum. 2010;53:1121–6.CrossRefPubMed
23.
Dale W, Hemmerich J, Kamm A, Posner MC, Matthews JB, Rothman R, et al. Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014;259:960–5.CrossRefPubMed
24.
25.
Dutta SC, Chang SC, Coffey CS, et al. Health-related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol. 2002;168:164–7.CrossRefPubMed
26.
Hart S, Skinner EC, Meyerowitz BE, et al. Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch. J Urol. 1999;162:77–81.CrossRefPubMed
27.
Forner DM, Lampe B. Ileal conduit and continent ileocecal pouch for patients undergoing pelvic exenteration: comparison of complications and quality of life. Int J Gynecol Cancer. 2011;21:403–8.
28.
Gerharz EW, Mansson A, Hunt S, et al. Quality of life after cystectomy and urinary diversion: an evidence-based analysis. J Urol. 2005;174:1729–36.CrossRefPubMed
29.
Chiva LM, Lapuente F, Nunez C, Ramirez PT. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer. Gynecol Oncol. 2009;113:47–51.CrossRefPubMed
30.
Goldberg GL, Sukumvanich P, Einstein MH, et al. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987–2003). Gynecol Oncol. 2006;101:261–8.CrossRefPubMed
31.
Smith HO, Genesen MC, Runowicz CD, et al. The rectus abdominis myocutaneous flap: modifications, complications, and sexual function. Cancer. 1998;83:510–20.CrossRefPubMed
32.
Ratliff CR, Gershenson DM, Morris M, et al. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996;78:2229–35.CrossRefPubMed
33.
Corney RH, Crowther ME, Everett H, Howells A, Shepherd JH. Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol. 1993;100:73–8.CrossRefPubMed
34.
35.
Krouse R, Grant M, Ferrell B, et al. Quality of life outcomes in 599 cancer and non-cancer patients with colostomies. J Surg Res. 2007:138:79–87.CrossRefPubMed
36.
Watson PG. The effects of short-term postoperative counseling on cancer/ostomy patients. Cancer Nurs. 1983;6:21–9.CrossRefPubMed
37.
Pomel C, Rouzier R, Pocard M, et al. Laparoscopic total pelvic exenteration for cervical cancer relapse. Gynecol Oncol. 2003;91:616–8.CrossRefPubMed
38.
Puntambekar S, Sharma V, Jamkar AV, Gadkari Y, Joshi G, Puntambekar S, et al. Our experience of laparoscopic anterior exenteration in locally advanced cervical carcinoma. J Minim Invasive Gynecol. 2016;23:396–403.CrossRefPubMed
39.
de la GJ, Wilson SS, Behbakht K. Total pelvic exenteration with a split-thickness skin graft neovagina, continent orthotopic neobladder, and rectal reanastomosis, resulting in no external ostomies and adequate sexual function. Gynecol Oncol. 2009;115:312–3.CrossRefPubMed
Metadata
Title
Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study
Authors
A. Martinez, PhD, MD
T. Filleron, PhD, MD
P. Rouanet, PhD, MD
P. Méeus, PhD, MD
E. Lambaudie, PhD, MD
J. M. Classe, PhD, MD
F. Foucher, MD
F. Narducci, MD
S. Gouy, PhD, MD
F. Guyon, PhD, MD
F. Marchal, PhD, MD
E. Jouve, MD
P. E. Colombo, PhD, MD
A. Mourregot, MD
M. Rivoire, PhD, MD
N. Chopin, MD
G. Houvenaeghel, PhD, MD
I. Jaffre, MD
J. Leveque, PhD, MD
V. Lavoue, PhD, MD
E. Leblanc, PhD, MD
P. Morice, PhD, MD
E. Stoeckle, PhD, MD
J. L. Verheaghe, MD
D. Querleu, PhD, MD
G. Ferron, PhD, MD
Publication date
01-02-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6120-z

Other articles of this Issue 2/2018

Annals of Surgical Oncology 2/2018 Go to the issue

Endocrine Tumors

Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis

Pancreatic Tumors

T-Helper 1 Immune Response in Metastatic Lymph Nodes of Pancreatic Ductal Adenocarcinoma: A Marker For Prolonged Survival

Breast Oncology

How Low Can We Go—and Should We? Risk Reduction for Minimal-Volume DCIS

Neuro-Oncology

Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection

Breast Oncology

Impact of Neoadjuvant Chemotherapy on Nodal Disease and Nodal Surgery by Tumor Subtype

Thoracic Oncology

Impact of Sarcopenia on Unplanned Readmission and Survival After Esophagectomy in Patients with Esophageal Cancer